Document is current
Any future updates will be listed below
-
Authors
Omilian, Angela R.
Mendicino, Lucas
George, Anthony
Darabnoushtehrani, Tina
Ondracek, Rochelle Payne
Bshara, Wiam
Hong, Chi-Chen
Qin, Bo
Bandera, Elisa V.
Khoury, Thaer
Cannioto, Rikki
Yao, Song
Ambrosone, Christine B.
-
Funding
Funding for this research was provided by:
National Cancer Institute (R03 CA238792, R01 CA185623, R01 CA185623, R01 CA247281, R01 CA247281)
National Institute on Minority Health and Health Disparities (R00 MD013300)
Centers for Disease Control and Prevention (NU5U58DP006279-02-00)
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 12 February 2025
Accepted: 12 June 2025
First Online: 1 July 2025
Competing interests
: E.V.B. served as a member of Pfizer’s Advisory Board to enhance minority participation in clinical trials (7/2021-8/2023). The other authors declare no potential conflicts of interest.
